newsfilter
← Latest News
Business Wire·

enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum

enGene Holdings Inc. (NASDAQ:ENGN), a clinical-stage, non-viral genetic medicines company, today announced that Ron Cooper, Chief Executive Officer, will present at the Stifel 2025 Virtual Targeted Oncology Forum, on